TELCON RF PHARMACEUTICAL. Inc. (KOSDAQ:200230)
South Korea flag South Korea · Delayed Price · Currency is KRW
3,885.00
+165.00 (4.44%)
May 13, 2025, 3:30 PM KST

TELCON RF PHARMACEUTICAL. Revenue

In the year 2024, TELCON RF PHARMACEUTICAL. had annual revenue of 37.87B KRW with 4.29% growth. TELCON RF PHARMACEUTICAL. had revenue of 13.84B in the quarter ending December 31, 2024, with 7.07% growth.

Revenue
37.87B
Revenue Growth
+4.29%
P/S Ratio
1.23
Revenue / Employee
298.15M
Employees
127
Market Cap
46.72B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202437.87B1.56B4.29%
Dec 31, 202336.31B8.48B30.46%
Dec 31, 202227.83B-10.01B-26.46%
Dec 31, 202137.84B4.70B14.18%
Dec 31, 202033.14B-23.45B-41.44%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Electronics 308.07T
SK hynix 71.40T
SK Square 6,138.47B
LG Electronics 89.37T
LG Corp. 7,175.51B
Samsung SDS 14.07T
Samsung Electro-Mechanics 10.29T
HANMI Semiconductor 558.92B
Revenue Rankings